DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr | ₹-139 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
| Mar2021 | ₹-139 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | Positive | |
| Mar2021 | ₹-139 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,553.7 Cr | 0.8% | -4.6% | 2.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹101,878.0 Cr | 4.2% | -0.6% | 2.3% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹97,669.9 Cr | 5.4% | -5.5% | -6.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹65,254.8 Cr | 2.6% | -5.5% | 33.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,887.8 Cr | 0.7% | -8.5% | 35.1% | Stock Analytics | |
| GLOBAL HEALTH | ₹29,943.2 Cr | 7.7% | -8.4% | 9.7% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 0.8% |
-4.6% |
2.9% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses